Kantoff PW - Search Results

1

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.

Oh WK, Vargas R, Jacobus S, Leitzel K, Regan MM, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali SM, Kantoff PW, Lipton A. Oh WK, et al. Among authors: kantoff pw. Cancer. 2011 Feb 1;117(3):517-25. doi: 10.1002/cncr.25394. Epub 2010 Sep 22. Cancer. 2011. PMID: 20862742 Free article.

2

Hormonal perturbations in patients with testicular cancer treated with cisplatin.

LeBlanc GA, Kantoff PW, Ng SF, Frei E 3rd, Waxman DJ. LeBlanc GA, et al. Among authors: kantoff pw. Cancer. 1992 May 1;69(9):2306-10. doi: 10.1002/1097-0142(19920501)69:9<2306::aid-cncr2820690917>3.0.co;2-f. Cancer. 1992. PMID: 1562977

3

Bladder cancer.

Kantoff PW. Kantoff PW. Curr Probl Cancer. 1990 Sep-Oct;14(5):233-92. doi: 10.1016/0147-0272(90)90016-j. Curr Probl Cancer. 1990. PMID: 2225921 Review.

4

Meningeal carcinomatosis from transitional cell carcinoma of the bladder.

Eng C, Cunningham D, Quade BJ, Schwamm L, Kantoff PW, Skarin AT. Eng C, et al. Among authors: kantoff pw. Cancer. 1993 Jul 15;72(2):553-7. doi: 10.1002/1097-0142(19930715)72:2<553::aid-cncr2820720236>3.0.co;2-z. Cancer. 1993. PMID: 8319186

5

Two differentially expressed genes in normal human prostate tissue and in carcinoma.

Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. Wang FL, et al. Among authors: kantoff pw. Cancer Res. 1996 Aug 15;56(16):3634-7. Cancer Res. 1996. PMID: 8705997

6

The prostate specific antigen. Its use as a tumor marker for prostate cancer.

Kantoff PW, Talcott JA. Kantoff PW, et al. Hematol Oncol Clin North Am. 1994 Jun;8(3):555-72. Hematol Oncol Clin North Am. 1994. PMID: 8707772 Review.

7

The androgen receptor gene GGN microsatellite and prostate cancer risk.

Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. Platz EA, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):379-84. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610786 Clinical Trial.

8

Management of hormone refractory prostate cancer: current standards and future prospects.

Oh WK, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. J Urol. 1998 Oct;160(4):1220-9. J Urol. 1998. PMID: 9751323 Review.

9

Debrisoquine hydroxylase (CYP2D6) and prostate cancer.

Febbo PG, Kantoff PW, Giovannucci E, Brown M, Chang G, Hennekens CH, Stampfer M. Febbo PG, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1075-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9865424

10

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer.

Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR. Duque JL, et al. Among authors: kantoff pw. Urology. 1999 Sep;54(3):523-7. doi: 10.1016/s0090-4295(99)00167-3. Urology. 1999. PMID: 10475365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters